US Patent Issued to BGI SHENZHEN on March 18 for "Use of Megamonas funiformis in preventing and/or treating metabolic diseases" (Chinese Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,407, issued on March 18, was assigned to BGI SHENZHEN (Guangdong, China).

"Use of Megamonas funiformis in preventing and/or treating metabolic diseases" was invented by Ying Dai (Guangdong, China), Yuanqiang Zou (Guangdong, China) and Liang Xiao (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a use of Megamonas funiformis in the prevention and/or treatment of metabolic diseases. Megamonas funiformis has the function of preventing and/or treating metabolic diseases (such as obesity, diabetes, atherosclerosis-related diseases, cardiovascular disease and hyperuricemia)."

The patent was filed on Dec. 7, 2018, under Applica...